Joint Formulary & PAD

Semaglutide - Weight management in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Semaglutide
Indication :
Weight management in adults
Group Name :
Keywords :
obesity, weight loss, weight management, overweight
Brand Names Include :
Wegovy
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Semaglutide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Weight management in adults.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed semaglutide for obesity and weight management in line with NICE TA875.

A RED traffic light status has been agreed.

Please Note that there will be a phased implementation in line with the guidance issued by the Society for Endocrinology and Obesity Management Collaborative UK.  Initially patients who meet the eligibility criteria listed in phase 1 of the guidance will be prioritised for referral to the specialist weight management service to allow those with the combination of highest and most urgent clinical need to be assessed.

Please see guidelines for further information